Pioglitazone

Therapeutic Group

Blood Glucose Lowering Drugs, Excluding Insulin

Indication Dosage

Type 2 Diabetes Mellitus (alone Or Combined With Metformin Or Sulfonylurea, Or With Both, Or With Insulin): 

  • Adult: Initially 15-30 Mg Once Daily, Adjusted According To Response To 45 Mg Once Daily, In Elderly Patients, Initiate With the Lowest Possible Dose And Increase Gradually; Review Treatment After 3-6 Months And Regularly Thereafter For Risk-benefits Assessment. The dosage Of Concomitant Sulfonylurea Or Insulin May Need To Be Reduced. 
  • Children: Not Recommended.

Content

  • Tab 15mg /30mg /45mg: Pioglita Zone (as Nci) 15mg /50mg /45mg.

Pregnancy

Contraindicated Or Not Recommended

Stability

  • Thiazolidinedione

Contra Indications

  • History Of Heart Failure, Previous Or Active Bladder Cancer, Uninvestigated Macroscopic Haematuria, Dialysis, Diabetic Ketoacidosis, Pregnancy And Lactation.

Precautions

  • History Of Heart Failure, Previous Or Active Bladder Cancer, Uninvestigated Macroscopic Haematuria, Dialysis, Diabetic Ketoacidosis, Pregnancy And Lactation.

Lactation

  • Contraindicated or Not Recommended.

Side Effects

  • Gi Disturbances
  • Anaemia
  • Arthralgia
  • Dizziness
  • Haematuria
  • Headache
  • Hypoaesthesia
  • Impotence
  • Oedema
  • Vertigo
  • Visual Disturbances
  • Weight Gain
  • Altered Blood Lipids
  • Bladder Cancer
  • Fatigue
  • Hypoglycaemia
  • Insomnia
  • Proteinuria
  • Sweating
  • Rare: Liver Dysfunction.